SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-22-000061
Filing Date
2022-08-04
Accepted
2022-08-04 08:47:31
Documents
12
Period of Report
2022-08-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pirs-20220804.htm   iXBRL 8-K 36961
  Complete submission text file 0001583648-22-000061.txt   173902

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pirs-20220804.xsd EX-101.SCH 1938
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pirs-20220804_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pirs-20220804_pre.xml EX-101.PRE 12543
6 EXTRACTED XBRL INSTANCE DOCUMENT pirs-20220804_htm.xml XML 11153
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 221134905
SIC: 2834 Pharmaceutical Preparations